---
title: "Biopharma Royalty Powerhouse Dips Despite Beat-And-Raise Quarter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295121334.md"
description: "Ligand's stock experienced a decline at the beginning of Thursday following the release of their quarterly earnings report which surpassed expectations. Despite a strong performance in both earnings and sales, the biopharma royalty giant faced a dip in its stock value. The company's enduring strength was reflected in achieving better-than-expected results, attracting investor attention despite the setback in stock performance."
datetime: "2026-08-06T14:11:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295121334.md)
  - [en](https://longbridge.com/en/news/295121334.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295121334.md)
generator: "portal-rs"
---

# Biopharma Royalty Powerhouse Dips Despite Beat-And-Raise Quarter

Ligand's stock experienced a decline at the beginning of Thursday following the release of their quarterly earnings report which surpassed expectations. Despite a strong performance in both earnings and sales, the biopharma royalty giant faced a dip in its stock value. The company's enduring strength was reflected in achieving better-than-expected results, attracting investor attention despite the setback in stock performance.

### Related Stocks

- [LGND.US](https://longbridge.com/en/quote/LGND.US.md)

## Related News & Research

- [$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296632631.md)
- [Ranger Investment Management L.P. Acquires Shares of 257,596 Ligand Pharmaceuticals Incorporated $LGND](https://longbridge.com/en/news/296772770.md)
- [Nike Is Back at Its 2014 Price and Still Isn’t Cheap, and Wall Street Expects Earnings to Fall Another 18%](https://longbridge.com/en/news/296639305.md)
- [Nebius Is Raising Money Through a Debt Offering After a Major Run-Up. What This Means for NBIS Stock.](https://longbridge.com/en/news/296940713.md)
- [Diversify Advisory Services LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296585791.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**